secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2022-05-04T23:59:59+00:00
Accession:  0000950170-22-007400
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q1 revenue $30.6M (+33% YoY); narrows FY2022 guidance to $144M-$150M
--------------------------------------------------------------------------------

- Revenue $30.6M (+33.3% YoY); product revenue $25.7M (+40.9%).
- GAAP gross margin 14.5% vs 1.3% YoY; non-GAAP gross margin 14.8%.
- GAAP net loss ($36.9M) or ($0.78)/share; non-GAAP net loss ($31.9M) or ($0.67)/share.
- FY2022 revenue guidance narrowed to $144M-$150M (prior $142M-$150M), 40-46% growth.
- Appointed Dale E. Jones to Board; cash $335.6M; record Tablo Home console shipments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017022007400/0000950170-22-007400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017022007400/om-20220504.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-007400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer